相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Changes in the incidence and overall survival of patients with myeloproliferative neoplasms between 2002 and 2016 in the United States
Srdan Verstovsek et al.
LEUKEMIA & LYMPHOMA (2022)
Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemia
Naveen Pemmaraju et al.
LEUKEMIA RESEARCH (2022)
Thrombosis and hemorrhage in myeloproliferative neoplasms: The platelet perspective
Yiming Feng et al.
PLATELETS (2022)
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber et al.
BLOOD (2022)
Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real-life study
Ruth Stuckey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Platelet Function and Turnover in Essential Thrombocythemia: A Systematic Review
Joachim Kvernberg et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2021)
Unmet clinical needs in the management of CALR-mutated essential thrombocythaemia: a consensus-based proposal from the European LeukemiaNet
Alberto Alvarez-Larrán et al.
Lancet Haematology (2021)
Hemorrhage in Essential Thrombocythemia or Polycythemia Vera: Epidemiology, Location, Risk Factors, and Lessons Learned from the Literature
Christophe Nicol et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Evaluation of platelet function in essential thrombocythemia under different analytical conditions
Federico Lussana et al.
PLATELETS (2020)
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia
Bianca Rocca et al.
BLOOD (2020)
Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Patients with Essential Thrombocythemia may be Poor Responders to Enteric-Coated Aspirin, but not to Plain Aspirin
Mariangela Scavone et al.
THROMBOSIS AND HAEMOSTASIS (2020)
A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
Tarinee Rungjirajittranon et al.
BMC CANCER (2019)
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events A Systematic Review and Meta-analysis
Sean L. Zheng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Essential Thrombocythemia
Ayalew Tefferi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Diagnostic workflow for hereditary erythrocytosis and thrombocytosis
Mary Frances McMullin
Hematology-American Society of Hematology Education Program (2019)
Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms
Andreas Perrier-Cornet et al.
PLATELETS (2018)
Platelet characteristics in patients with essential thrombocytosis
Oliver Heidmann Pedersen et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2018)
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
Peter M. Bothwell et al.
LANCET (2018)
Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms
Ofir Wolach et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting
Valerio De Stefano et al.
BLOOD CANCER JOURNAL (2018)
Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia A Systematic Review
Derek K. Chu et al.
ANNALS OF INTERNAL MEDICINE (2017)
Refining prognostication of thrombosis in ET
Tiziano Barbui
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation
Alberto Alvarez-Larran et al.
HAEMATOLOGICA (2016)
Do we need antiplatelet therapy in thrombocytosis? Contra Proposal for an individualized risk-adapted treatment
Ruediger E. Scharf
HAMOSTASEOLOGIE (2016)
Do we need antiplatelet therapy in thrombocytosis? Pro Diagnostic and pathophysiologic considerations for a treatment choice
Lorenzo Alberio
HAMOSTASEOLOGIE (2016)
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation
Alberto Alvarez-Larran et al.
HAEMATOLOGICA (2016)
Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count
S. Lancellotti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Small bowel injury in low-dose aspirin users
Hiroki Endo et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Essential thrombocythemia vs. early/prefibrotic myelofibrosis: Why does it matter
Giovanni Barosi
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2014)
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
Elisa Rumi et al.
BLOOD (2014)
Increased mean platelet volume and immature platelet fraction as potential predictors of thrombotic complications in BCR/ABL-negative myeloproliferative neoplasms
Jarmila Kissova et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2014)
Cytoreduction plus low-dose aspirin versus cytoreduction alone as primary prophylaxis of thrombosis in patients with high-risk essential thrombocythaemia: an observational study
Alberto Alvarez-Larran et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Effect of platelet count on platelet aggregation measured with impedance aggregometry (Multiplate™ analyzer) and with light transmission aggregometry
E. A. Femia et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH
M. Cattaneo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera
Marina Panova-Noeva et al.
THROMBOSIS RESEARCH (2013)
PLATELETS & THROMBOPOIESIS Overcoming aspirin resistance in MPN
Ayalew Tefferi
BLOOD (2012)
Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort
Peter J. Campbell et al.
BLOOD (2012)
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target
Silvia Pascale et al.
BLOOD (2012)
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria
G. Finazzi et al.
LEUKEMIA (2012)
Twice daily aspirin to improve biological aspirin efficacy in patients with essential thrombocytemia
Jean-Guillaume Dillinger et al.
THROMBOSIS RESEARCH (2012)
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
Alessandra Carobbio et al.
BLOOD (2011)
The contribution of cyclooxygenase-1 and-2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy
Alfredo Dragani et al.
BLOOD (2010)
Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia
Alberto Alvarez-Larran et al.
BLOOD (2010)
An abnormal pattern of multiple platelet function abnormalities and increased thromboxane generation in patients with primary thrombocytosis and thrombotic complications
J. Zahavi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
The role of weight and enteric coating on aspirin response in cardiovascular patients
A. Peace et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
Tiziano Barbui et al.
BLOOD (2009)
Association of Cyclooxygenase-1-Dependent and -Independent Platelet Function Assays With Adverse Clinical Outcomes in Aspirin-Treated Patients Presenting for Cardiac Catheterization
Andrew L. Frelinger et al.
CIRCULATION (2009)
In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: Are they laboratory artefacts?
Claudio Grignani et al.
PLATELETS (2009)
Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review
Federico Lussana et al.
THROMBOSIS RESEARCH (2009)
Prevalence of polycythemia vera and essential thrombocythemia
Xiaomei Ma et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia
Alessandra Carobbio et al.
BLOOD (2008)
Megakaryopoiesis and platelet function in polycythemia vera and essential thrombocythemia patients with JAK2 V617F mutation
Norimichi Hattori et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Leukocytosis and risk stratification assessment in essential thrombocythemia
Alessandra Carobbio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Usefulness of PFA-100® testing in the diagnostic screening of patients with suspected abnormalities of hemostasis:: comparison with the bleeding time
G. M. Podda et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection
M. Cattaneo
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count
Marco Cattaneo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status
Alessandra Carobbio et al.
BLOOD (2007)
Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin
S. Guthikonda et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: A distinct aspirin-responsive and coumadin-resistant arterial thrombophilia
Jan Jacques Michiels et al.
PLATELETS (2006)
The paradox of platelet activation and impaired function: Platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera
Jan J. Michiels et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers
Dermot Cox et al.
STROKE (2006)
Epidemiology of the myeloproliferative disorders polycythemia vera and essential thrombocythemia
P Johansson
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Drug therapy -: Low-dose aspirin for the prevention of atherothrombosis
C Patrono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease
AO Maree et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100
JM Cesar et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Efficacy and safety of low-dose aspirin in polycythemia vera
R Landolfi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Abnormal vascular, platelet and coagulation markers in primary thrombocythaemia are not reversed by treatments that reduce the platelet count
A Blann et al.
PLATELETS (2004)
Aspirin and clopidogrel - Efficacy, safety, and the issue of drug resistance
M Cattaneo
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets
B Rocca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
JW Eikelboom et al.
CIRCULATION (2002)
Association between aspirin and upper gastrointestinal complications:: Systematic review of epidemiologic studies
LAG Rodríguez et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
分享论文
